Lung Cancers Completed Phase 2 Trials for Dasatinib (DB01254)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00570401Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or GefitinibTreatment